GR69741B - - Google Patents

Info

Publication number: GR69741B
Authority: GR; Greece

Application number

GR62506A

Inventor

Harald Furrer

Original Assignee

Hoechst Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1979-07-21

Filing date

1980-01-28

Publication date

1982-07-12

1980-01-28 Application filed by Hoechst Ag filed Critical Hoechst Ag

1982-07-12 Publication of GR69741B publication Critical patent/GR69741B/el

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

GR62506A 1979-07-21 1980-01-28 GR69741B (el)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19792929596 DE2929596A1 (de)	1979-07-21	1979-07-21	Verfahren zur herstellung von oxoalkyl-xanthinen

Publications (1)

Publication Number	Publication Date
GR69741B true GR69741B (el)	1982-07-12

Family

ID=6076378

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GR62506A GR69741B (el)	1979-07-21	1980-01-28

Country Status (9)

Country	Link
EP (1)	EP0023032A1 (el)
JP (1)	JPS5616486A (el)
AR (1)	AR227645A1 (el)
DE (1)	DE2929596A1 (el)
DK (1)	DK311580A (el)
ES (1)	ES8105005A1 (el)
FI (1)	FI802267A (el)
GR (1)	GR69741B (el)
NO (1)	NO802173L (el)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0042706B1 (en) *	1980-06-21	1985-12-27	BEECHAM - WUELFING GmbH & Co. KG	Xanthine derivatives, pharmaceutical compositions containing them and a process for their preparation
GB8418430D0 (en) *	1984-07-19	1984-08-22	Beecham Wuelfing Gmbh & Co Kg	Treatment
GB8501488D0 (en) *	1985-01-21	1985-02-20	Beecham Group Plc	Treatment
US4851060A (en) *	1987-08-12	1989-07-25	Essex Group, Inc.	Multilayer wrapped insulated magnet wire
CA2030112A1 (en) *	1989-11-24	1991-05-25	Yasuo Ito	Xanthine compound, method for preparing thereof, and a pharmaceutical composition comprising the same
DE3942872A1 (de) *	1989-12-23	1991-06-27	Hoechst Ag	Verfahren zur enantioselektiven darstellung von ((omega)-1)-hydroxyalkylxanthinen
EP0570831A2 (de) *	1992-05-20	1993-11-24	Hoechst Aktiengesellschaft	Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation
US7407955B2 (en)	2002-08-21	2008-08-05	Boehringer Ingelheim Pharma Gmbh & Co., Kg	8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7501426B2 (en)	2004-02-18	2009-03-10	Boehringer Ingelheim International Gmbh	8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de)	2004-11-05	2006-05-11	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de)	2005-07-30	2007-02-08	Boehringer Ingelheim Pharma Gmbh & Co. Kg	8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
EP1852108A1 (en)	2006-05-04	2007-11-07	Boehringer Ingelheim Pharma GmbH & Co.KG	DPP IV inhibitor formulations
EA030606B1 (ru)	2006-05-04	2018-08-31	Бёрингер Ингельхайм Интернациональ Гмбх	Способы приготовления лекарственного средства, содержащего полиморфы
PE20080251A1 (es)	2006-05-04	2008-04-25	Boehringer Ingelheim Int	Usos de inhibidores de dpp iv
PE20140960A1 (es)	2008-04-03	2014-08-15	Boehringer Ingelheim Int	Formulaciones que comprenden un inhibidor de dpp4
UY32030A (es)	2008-08-06	2010-03-26	Boehringer Ingelheim Int	"tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
BRPI0916997A2 (pt)	2008-08-06	2020-12-15	Boehringer Ingelheim International Gmbh	Inibidor de dpp-4 e seu uso
EP2344195A2 (en)	2008-09-10	2011-07-20	Boehringer Ingelheim International GmbH	Combination therapy for the treatment of diabetes and related conditions
US20200155558A1 (en)	2018-11-20	2020-05-21	Boehringer Ingelheim International Gmbh	Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
BRPI0923121A2 (pt)	2008-12-23	2015-08-11	Boehringer Ingelheim Int	Formas salinas de compostos orgânico
TW201036975A (en)	2009-01-07	2010-10-16	Boehringer Ingelheim Int	Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy
ES2760917T3 (es)	2009-11-27	2020-05-18	Boehringer Ingelheim Int	Tratamiento de pacientes diabéticos genotipificados con inhibidores DPP-IV como la linagliptina
JP6034781B2 (ja)	2010-05-05	2016-11-30	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	併用療法
EA201991014A1 (ru)	2010-06-24	2019-09-30	Бёрингер Ингельхайм Интернациональ Гмбх	Лечение диабета
US9034883B2 (en)	2010-11-15	2015-05-19	Boehringer Ingelheim International Gmbh	Vasoprotective and cardioprotective antidiabetic therapy
MX366629B (es)	2011-07-15	2019-07-17	Boehringer Ingelheim Int	Quinazolinas sustituidas, su preparación y su uso en composiciones farmacéuticas.
US9555001B2 (en)	2012-03-07	2017-01-31	Boehringer Ingelheim International Gmbh	Pharmaceutical composition and uses thereof
EP3685839A1 (en)	2012-05-14	2020-07-29	Boehringer Ingelheim International GmbH	Linagliptin for use in the treatment of albuminuria and kidney related diseases
WO2013174767A1 (en)	2012-05-24	2013-11-28	Boehringer Ingelheim International Gmbh	A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
JP2019517542A (ja)	2016-06-10	2019-06-24	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	リナグリプチンおよびメトホルミンの組合せ

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2336403A1 (fr) *	1975-12-24	1977-07-22	Bruneau & Cie Lab	Nouveau procede de preparation de l'acide (theophyllinyl-7)-3 propanesulfonique
GB1527543A (en) *	1976-04-15	1978-10-04	Degussa	Basically substituted xanthine derivatives
DE2714953C2 (de) *	1977-04-02	1986-09-25	Hoechst Ag, 6230 Frankfurt	Arzneimittel

1979
- 1979-07-21 DE DE19792929596 patent/DE2929596A1/de not_active Withdrawn
1980
- 1980-01-28 GR GR62506A patent/GR69741B/el unknown
- 1980-07-15 ES ES493385A patent/ES8105005A1/es not_active Expired
- 1980-07-17 EP EP80104171A patent/EP0023032A1/de not_active Withdrawn
- 1980-07-17 FI FI802267A patent/FI802267A/fi not_active Application Discontinuation
- 1980-07-18 AR AR281813A patent/AR227645A1/es active
- 1980-07-18 DK DK311580A patent/DK311580A/da unknown
- 1980-07-18 NO NO802173A patent/NO802173L/no unknown
- 1980-07-21 JP JP9883880A patent/JPS5616486A/ja active Pending

Also Published As

Publication number	Publication date
JPS5616486A (en)	1981-02-17
ES493385A0 (es)	1981-05-16
NO802173L (no)	1981-01-22
EP0023032A1 (de)	1981-01-28
ES8105005A1 (es)	1981-05-16
AR227645A1 (es)	1982-11-30
DE2929596A1 (de)	1981-02-05
DK311580A (da)	1981-01-22
FI802267A (fi)	1981-01-22

Publication	Publication Date	Title
BR8002583A (el)	1980-12-09
FR2449051B1 (el)	1984-04-20
FR2447354B1 (el)	1984-11-02
FR2447035B1 (el)	1984-01-13
BR8006808A (el)	1981-04-28
FR2447218B1 (el)	1984-05-11
DE3050231A1 (el)	1982-08-19
FR2448080B1 (el)	1983-03-11
FR2446478B1 (el)	1983-02-25
DE2947457C2 (el)	1987-03-19
FR2446545B1 (el)	1984-04-06
FR2446717B1 (el)	1981-12-11
FR2444827B1 (el)	1983-05-20
FR2448103B3 (el)	1982-10-01
DE2908021C2 (el)	1985-02-14
AT364253B (el)	1981-10-12
AU79558S (el)	1981-09-11
AU77669S (el)	1980-09-29
AU78389S (el)	1980-09-29
AU78390S (el)	1980-06-23
AU78391S (el)	1980-11-26
AU78569S (el)	1980-05-19
AU79200S (el)	1980-09-25
AU79557S (el)	1981-06-03
AU80228S (el)	1980-09-09